Gemphire Therapeutics Inc Banner Image

Gemphire Therapeutics Inc

  • Ticker GEMP
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Gemphire Therapeutics Inc Logo Image
  • 11-50 Employees
  • Based in Livonia, Michigan
Gemphire is a clinical-stage biopharmaceutical company that is committed to helping patients with cardiometabolic disorders, including dyslipidemia and NASH. They are focused on providing new treatment options for cardiometabolic diseases through there complementary, convenient, cost-effective product candidate gemcabene as add-on to the standard of care especially statins that will benefitMore patients, physicians, and payors.
4.8 / 5.0 (136)

Gemphire Therapeutics Inc reports have an aggregate usefulness score of 4.8 based on 136 reviews.

Gemphire Therapeutics Inc

Most Recent Annual Report

Gemphire Therapeutics Inc
MOST RECENT 2020 Annual Report, 2018 Form 10K

Gemphire Therapeutics Inc does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Gemphire Therapeutics Inc Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!